2024 - Strategic Advantages of Early-Phase Oncology Clinical Development Across Australia and the USA

Discover an informative webinar that delves into the strategic benefits of conducting early-phase oncology clinical development across Australia and the USA.
Australia’s unique advantages make it an ideal starting point for early-phase oncology trials. The Therapeutic Goods Administration Clinical Trial Notification scheme offers a streamlined regulatory pathway, significantly accelerating trial initiation. Coupled with world-class research centers and a generous research and development (R&D) tax incentive — allowing biotechnology companies to reclaim up to 43.5 percent of their R&D expenditures — Australia provides a conducive environment for rapid and cost-effective early-phase development.
Read more...
Register for this webinar today to learn about the strategic advantages of early-phase oncology clinical development in Australia and the USA and how it helps ensure innovative cancer therapies reach the market.
Keywords: Clinical Trials, Drug Development, Clinical Research, CRO, Oncology, Regulatory, Oncology Trials, Oncology Clinical Trials, Therapeutic Areas, Clinical Trials Australia, Sites